Templar57
Nov 17, 11:18 AM
$AVR DurAVR’s ComASUR delivery system could give physicians a second reason to choose DurAVR alongside its hemodynamics: more predictable placement and easier coronary access down the road. If Anteris can show those benefits consistently across PARADIGM sites and operators, the delivery system could matter as much to adoption as the early valve data suggest the valve itself might.
1 replies